ki:elements Publishes New Validation Results on Remote Speech Biomarker for Cognition (SB-C) in Early Alzheimer's Disease

ki:elementsDigital speech biomarker company ki:elements has published validation results on the use of its ki:e speech biomarker for cognition (SB-C) in early Alzheimer’s disease in the "Karger - Digital Biomarkers" journal.(1)

Two European dementia studies - the Dutch DeepSpA study in collaboration with Maastricht University & the Scottish SPeAK study in collaboration with University of Edinburgh - helped to validate the psychometric properties of the SB-C. Results demonstrate the ki:e SB-C's ability to differentiate subjective complaints from people with mild cognitive impairment, and its ability to track decline towards Mild Cognitive Impairment in early phases of the disease within a year. On a construct level the SB-C score is correlated with established measures for cognition and its domain scores are anchored around established assessments for neurocognitive functions such as learning and memory, executive function and processing speed. In the longitudinal DeepSpA study the SB-C shows also good test-retest reliability. Validation followed the V3 approach championed by the Digital Medicine Society (DiMe).

Prof. Craig Ritchie, Chair of the Psychiatry of Ageing and Director of the Centre for Dementia Prevention at the University of Edinburgh, and PI of the SpEAK study commented: "Early detection of AD is the prerequisite for prevention. These results show that speech is a scalable and sensitive screening tool that could be a key building block in ending AD."

Dr. Johannes Tröger, Chief Scientific Officer of ki:elements added: "We are pleased with these validation results in early AD, validating that SB-C is a reliable measure of cognition - usable in clinical trials and healthcare. In parallel, we are working on studies validating the SB-C in even earlier, preclinical stages of the disease."

About ki:elements and SB-C

ki:elements GmbH is pioneering the research and development of novel digital speech biomarkers. The ki:e speech biomarker for cognition (SB-C) is a speech based cognitive digital biomarker that takes fifteen minutes to complete, can be administered remotely and automatically. It is used in academic and pharmaceutical research as a scalable cognition measurement and screening tool.

For more information, visit https://ki-elements.de

1. Tröger J, Baykara E, Zhao J, ter Huurne D, Possemis N, Mallick E, Schäfer S, Schwed L, Mina M, Linz N, Ramakers I, Ritchie C.
Validation of the Remote Automated ki:e Speech Biomarker for Cognition in Mild Cognitive Impairment: Verification and Validation following DiME V3 Framework.
Digit Biomark 2022;6:107-116. doi: 10.1159/000526471

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Computer Models Open Door to Far Mor…

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...